These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

858 related items for PubMed ID: 17261671

  • 1. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
    Brown JD, Plutzky J.
    Circulation; 2007 Jan 30; 115(4):518-33. PubMed ID: 17261671
    [Abstract] [Full Text] [Related]

  • 2. PPARs and their metabolic modulation: new mechanisms for transcriptional regulation?
    Ahmed W, Ziouzenkova O, Brown J, Devchand P, Francis S, Kadakia M, Kanda T, Orasanu G, Sharlach M, Zandbergen F, Plutzky J.
    J Intern Med; 2007 Aug 30; 262(2):184-98. PubMed ID: 17645586
    [Abstract] [Full Text] [Related]

  • 3. Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.
    Gervois P, Fruchart JC, Staels B.
    Nat Clin Pract Endocrinol Metab; 2007 Feb 30; 3(2):145-56. PubMed ID: 17237841
    [Abstract] [Full Text] [Related]

  • 4. International Union of Pharmacology. LXI. Peroxisome proliferator-activated receptors.
    Michalik L, Auwerx J, Berger JP, Chatterjee VK, Glass CK, Gonzalez FJ, Grimaldi PA, Kadowaki T, Lazar MA, O'Rahilly S, Palmer CN, Plutzky J, Reddy JK, Spiegelman BM, Staels B, Wahli W.
    Pharmacol Rev; 2006 Dec 30; 58(4):726-41. PubMed ID: 17132851
    [Abstract] [Full Text] [Related]

  • 5. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
    Giaginis C, Tsantili-Kakoulidou A, Theocharis S.
    Fundam Clin Pharmacol; 2007 Jun 30; 21(3):231-44. PubMed ID: 17521292
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
    Marx N, Duez H, Fruchart JC, Staels B.
    Circ Res; 2004 May 14; 94(9):1168-78. PubMed ID: 15142970
    [Abstract] [Full Text] [Related]

  • 7. PPAR ligands: are they potential agents for cardiovascular disorders?
    Balakumar P, Rose M, Singh M.
    Pharmacology; 2007 May 14; 80(1):1-10. PubMed ID: 17496434
    [Abstract] [Full Text] [Related]

  • 8. A PPARs cross-talk concertedly commits C6 glioma cells to oligodendrocytes and induces enzymes involved in myelin synthesis.
    Leisewitz AV, Urrutia CR, Martinez GR, Loyola G, Bronfman M.
    J Cell Physiol; 2008 Nov 14; 217(2):367-76. PubMed ID: 18543250
    [Abstract] [Full Text] [Related]

  • 9. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
    Touyz RM, Schiffrin EL.
    Vascul Pharmacol; 2006 Jul 14; 45(1):19-28. PubMed ID: 16782410
    [Abstract] [Full Text] [Related]

  • 10. Evolution of peroxisome proliferator-activated receptor agonists.
    Chang F, Jaber LA, Berlie HD, O'Connell MB.
    Ann Pharmacother; 2007 Jun 14; 41(6):973-83. PubMed ID: 17519293
    [Abstract] [Full Text] [Related]

  • 11. Peroxisome proliferator-activated receptor family and its relationship to renal complications of the metabolic syndrome.
    Guan Y.
    J Am Soc Nephrol; 2004 Nov 14; 15(11):2801-15. PubMed ID: 15504933
    [Abstract] [Full Text] [Related]

  • 12. PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.
    Collino M, Patel NS, Thiemermann C.
    Ther Adv Cardiovasc Dis; 2008 Jun 14; 2(3):179-97. PubMed ID: 19124421
    [Abstract] [Full Text] [Related]

  • 13. Inflammation in diabetes mellitus: role of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma agonists.
    Libby P, Plutzky J.
    Am J Cardiol; 2007 Feb 19; 99(4A):27B-40B. PubMed ID: 17307056
    [Abstract] [Full Text] [Related]

  • 14. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
    Yumuk VD.
    Ann N Y Acad Sci; 2006 Nov 19; 1083():306-18. PubMed ID: 17148746
    [Abstract] [Full Text] [Related]

  • 15. Expression of peroxisome proliferator-activated receptors (PPARs) and retinoic acid receptors (RXRs) in rat cortical neurons.
    Cimini A, Benedetti E, Cristiano L, Sebastiani P, D'Amico MA, D'Angelo B, Di Loreto S.
    Neuroscience; 2005 Nov 19; 130(2):325-37. PubMed ID: 15664689
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptors and inflammation: take it to heart.
    Smeets PJ, Planavila A, van der Vusse GJ, van Bilsen M.
    Acta Physiol (Oxf); 2007 Nov 19; 191(3):171-88. PubMed ID: 17935522
    [Abstract] [Full Text] [Related]

  • 17. PPAR agonists and the metabolic syndrome.
    Staels B.
    Therapie; 2007 Nov 19; 62(4):319-26. PubMed ID: 17983557
    [Abstract] [Full Text] [Related]

  • 18. Healing the diabetic heart: modulation of cardiometabolic syndrome through peroxisome proliferator activated receptors (PPARs).
    Huang TH, Roufogalis BD.
    Curr Mol Pharmacol; 2012 Jun 19; 5(2):241-7. PubMed ID: 22122453
    [Abstract] [Full Text] [Related]

  • 19. PPARs as therapeutic targets in cardiovascular disease.
    van Bilsen M, van Nieuwenhoven FA.
    Expert Opin Ther Targets; 2010 Oct 19; 14(10):1029-45. PubMed ID: 20854178
    [Abstract] [Full Text] [Related]

  • 20. Inflammatory reaction versus endogenous peroxisome proliferator-activated receptors expression, re-exploring secondary organ complications of spontaneously hypertensive rats.
    Sun L, Ke Y, Zhu CY, Tang N, Tian DK, Gao YH, Zheng JP, Bian K.
    Chin Med J (Engl); 2008 Nov 20; 121(22):2305-11. PubMed ID: 19080338
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.